World Sepsis Congress: Spotlight 2020


The congress has concluded. All sessions were recorded and have been released in 6 separate presentations via YouTube and as a podcast on Apple Podcasts.

View the program Program+WSC+Spotlight+2020

Welcome Remarks by the Program Chairs WHO & GSA. See:

Session 1 – Opening Session View Session 1

  • WHO Response to Global Health Threats: Sepsis, AMR, and COVID-19
    Tedros Adhanom Ghebreyesus, Director-General, World Health Organization, Switzerland
  • Entering a New Era for Tackling AMR
    Hanan Balkhy, Assistant Director-General, World Health Organization, Switzerland
  • Keynote: The Next Generation of Environmentally Friendly Antibiotics
    Ada Yonath, Nobel Prize Laureate, Weizmann Institute of Science, Israel
  • Vaccination Saves Lives through Prevention of Sepsis
    Seth Berkley, GAVI, the Vaccine Alliance, Switzerland
  • The Patient Safety Dimension
    Liam Donaldson, WHO Envoy for Patient Safety, United Kingdom

Session 2 – The Epidemiology and Burden of Sepsis View Session 2

  • Keynote: The Global Burden of Sepsis
    Kristina Rudd, University of Pittsburgh, United States of America
  • The Burden of Maternal Sepsis in Fragile Populations
    Zenaida Recidoro, National Safe Mother Program Department of Health, Philippines
  • The Burden of Sepsis in Children and Neonates: Lessons Learned from Lowand Middle-Income Countries (LMICs)
    Matthew Westercamp, Centers for Disease Control and Prevention, United States of America
  • Challenges in Implementing Sepsis and AMR Surveillance
    Uduak Okomo, Medical Research Council Unit The Gambia at London School of
    Hygiene and Tropical Medicine, The Gambia
  • Drivers of and Inequalities in the Burden of Sepsis in LMICs
    Flavia Machado, Global Sepsis Alliance, Brazil

Session 3 – Antimicrobial Resistance: An Emerging Global Health Threat View Session 3

  • Keynote: One-Health-Approach to AMR and Global Health Threats
    Ilaria Capua, Emerging Pathogens Institute, University of Florida, United States of America
  • Novel Medicines Project: Driving Reinvestment in Research and Development and Responsible Antibiotic Use
    Stephan Harbarth, Infection Control Programme, Geneva University Hospitals, Switzerland
  • Cost-Effective Interventions to Combat AMR
    Imran Hasan, International Centre for Diarrhoeal Disease Research, Bangladesh
  • AMR in Neonates and Children with Sepsis in LMICs
    Mike Sharland, St George‘s University Hospitals NHS Foundation Trust, United Kingdom
  • Antimicrobial Stewardship in Limiting Multi Drug Resistant Organisms
    Jameela Alsalman, Ministry of Health, Bahrain

Session 4 – Sepsis, Ebola, and COVID-19 View Session 4

  • Keynote: WHO Clinical Response to Sepsis, COVID-19, and Ebola
    Janet Diaz, World Health Organization, United States of America
  • Managing Sepsis in COVID-19 Patients – Special Considerations
    Hala Abuzeid, Abu Dhabi Health Service, United Arab Emirates
  • COVID-19 Therapeutics: What We Have Learned and Where We Are Going
    Marco Cavaleri, European Medicines Agency, The Netherlands
  • Mobile Emergency Care Units Ebola Sepsis Improve Survival
    Richard Kojan, The Alliance for International Medical Action, Democratic Republic of the Congo
  • Inflammatory Response Due to COVID-19 Infection
    Yee Sin Leo, National Centre for Infectious Diseases, Singapore

Session 5 – A Comprehensive and Integrated Approach to Preventing Sepsis and AMR View Session 5 

  • Keynote: Preventing Infection and Improving Health in LMICs: Lessons
    Learned from Water, Sanitation, and Hygiene Programmes Kelly Ann Naylor, UNICEF, United States of America
  • WHO Infection Prevention and Control Strategy to Prevent AMR and Sepsis
    Benedetta Allegranzi, World Health Organization, Switzerland
  • The Impact of Bacillus Calmette-Guérin (BCG) Vaccination on COVID-19 and Respiratory Infections
    Evangelos Giamarellos, European Sepsis Alliance, Greece
  • Aspects of AMR and Appropriate Antimicrobial Use in Critically Ill Patients
    Mervyn Mer, University of the Witwatersrand, Johannesburg, South Africa

Session 6 – Early Identification and Appropriate Clinical Management of Sepsis Saves Lives and Prevents AMR View Session 6

  • Keynote: Bringing the Fight Against Sepsis to the Next Level
    Konrad Reinhart, Global Sepsis Alliance, Germany
  • Management and Treatment of Possible Serious Bacterial Infection in Infants in Resource-Limited Settings
    Shally Awasthi, King George‘s Medical University, India
  • The Role of the Pathogen in the Management of Sepsis
    Arjen Dondorp, Asia Pacific Sepsis Alliance, Thailand
  • Pediatric Sepsis: Guidelines and More
    Rana Sharara-Chami, American University of Beirut Medical Center, Lebanon
  • The Role of Sepsis and AMR for Patient Safety
    Abdulelah Al-Hawsawi, Saudi Patient Safety Center, Saudi Arabia
  • Closing Remarks:
    Edward Kelley, Director, Integrated Health Services, WHO, Switzerland
    Niranjan ’Tex’ Kissoon, GSA, Canada